Clinical Report: Variability in HbA1c Levels and Renal Function in Older Adults
Overview
This study investigates the association between visit-to-visit HbA1c variability and renal function decline in older adults with type 2 diabetes.
Background
The management of type 2 diabetes in older adults is complex due to the interplay of diabetes, chronic kidney disease, and aging. Renal function decline is a significant complication that can lead to increased morbidity and mortality.
Data Highlights
Measure
Value
Participants
630
Mean Age
72.9 years
Median Follow-up
4.6 years
Primary Renal Events
247
HR per 5% increase in HbA1c-CV
1.19 (95% CI 1.08–1.31; p < 0.001)
HR for highest tertile vs lowest
1.58 (95% CI 1.18–2.11; p = 0.002)
Key Findings
Visit-to-visit HbA1c variability is associated with renal function decline in older adults with type 2 diabetes.
Each 5% increase in HbA1c coefficient of variation (HbA1c-CV) correlates with a higher risk of renal decline.
Participants in the highest tertile of HbA1c-CV had a significantly increased risk of renal events compared to those in the lowest tertile.
Results were consistent across competing-risk and lagged analyses.
Incremental predictive value of HbA1c variability beyond established kidney markers was not assessed in this study.
Clinical Implications
Healthcare providers should consider HbA1c variability as a potential indicator of renal risk in older adults with type 2 diabetes. Monitoring glycemic stability may enhance the understanding of individual patient risks and inform management strategies.
Conclusion
The findings indicate that greater variability in HbA1c levels is linked to renal function decline in older adults with type 2 diabetes.
